Assignee
RENAGADE THERAPEUTICS MAN INC
US·6 granted patents·10 pending applications·0 citations·filing 2022–2025
Top patents by PatentIndex Score
16 records- 0179US12264328B2Gene editing components, systems, and methods of useRENAGADE THERAPEUTICS MAN INC·Filed 2023·Granted Apr 1, 2025·0 cites·16 claims
- 0278US12054739B2Engineered retrons and methods of useRENAGADE THERAPEUTICS MAN INC·Filed 2023·Granted Aug 6, 2024·0 cites·30 claims
- 0377US2025154533A1Engineered retrons and methods of useRENAGADE THERAPEUTICS MAN INC·Filed 2024·Application pending·0 cites
- 0475US11866728B2Engineered retrons and methods of useRENAGADE THERAPEUTICS MAN INC·Filed 2022·Granted Jan 9, 2024·0 cites·30 claims
- 0568US11773061B2Cyclic lipids and methods of use thereofRENAGADE THERAPEUTICS MAN INC·Filed 2022·Granted Oct 3, 2023·0 cites·30 claims
- 0668US2024182412A1Cyclic lipids and methods of use thereofRENAGADE THERAPEUTICS MAN INC·Filed 2023·Application pending·0 cites
- 0766US12545636B2Acyclic lipids and methods of use thereofRENAGADE THERAPEUTICS MAN INC·Filed 2022·Granted Feb 10, 2026·0 cites·17 claims
- 0865US2024084274A1Gene editing components, systems, and methods of useRENAGADE THERAPEUTICS MAN INC·Filed 2023·Application pending·0 cites
- 0964US2025154102A1Cyclic lipids and methods of use thereofRENAGADE THERAPEUTICS MAN INC·Filed 2024·Application pending·0 cites
- 1064US2024130969A1Lipid nanoparticles and methods of use thereofRENAGADE THERAPEUTICS MAN INC·Filed 2023·Application pending·0 cites
- 1164US2025313525A1Constrained lipids and methods of use thereofRENAGADE THERAPEUTICS MAN INC·Filed 2024·Application pending·0 cites
- 1263US12215068B2Constrained lipids and methods of use thereofRENAGADE THERAPEUTICS MAN INC·Filed 2023·Granted Feb 4, 2025·0 cites·30 claims
- 1363US2026062700A1Engineered retrons and methods of useRENAGADE THERAPEUTICS MAN INC·Filed 2023·Application pending·0 cites
- 1463US2024200118A1Compositions and methods for optimizing tropism of delivery systems for rnaRENAGADE THERAPEUTICS MAN INC·Filed 2024·Application pending·0 cites
- 1561US2025340901A1Gene editing components, systems, and methods of useRENAGADE THERAPEUTICS MAN INC·Filed 2025·Application pending·0 cites
- 1660US2025367322A1Nucleobase editing system and method of using same for modifying nucleic acid sequencesRENAGADE THERAPEUTICS MAN INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when RENAGADE THERAPEUTICS MAN INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →